Anxiety Disorders And Depression Treatment Market Growth & Trends
The global anxiety disorders and depression treatment market is expected to reach a value of USD 15.88 billion by 2030. The market is projected to grow at a CAGR of 3.6% from 2024 to 2030. The rising incidence of depression worldwide is anticipated to drive the market growth in the coming years. Increasing adoption of devices and psychotherapies has resulted in the declining demand for antidepressants in recent years.
The rising geriatric population prone to depression and surging prevalence of anxiety disorders, including phobias and generalized anxiety disorder, are further contributing toward the growing demand for antidepressants to treat mental illnesses over the forecast period. Moreover, the introduction of technologically advanced therapies, such as medical implants used for brain stimulation and virtual reality exposure therapies using smartphone-based applications, furnish patients with innovative treatment alternatives.
Anxiety Disorders And Depression Treatment Market Report Highlights
- Presently, the antidepressant drugs segment holds the largest revenue share. However, due to the rising occurrence of adverse events associated with these therapeutics, this segment’s growth is expected to wane
- Patent expiration of branded medicines and the introduction of generic biosimilars, which are cost-effective, are responsible for the shrinking market of antidepressants
- On the other hand, the introduction of new medicines, such as Duloxetine, Fetzima, and Brintellix, is predicted to fuel the demand for therapeutics in the coming years
- Furthermore, the personalized therapies and devices segment is expected to register the fastest growth owing to its growing adoption by healthcare professionals as they exert fewer side effects as compared to drugs
- North American regional segment for anxiety disorders and depression treatment reached a saturation level owing to the availability of several medicines and the high prevalence of depressive disorders in this region
- The revenue captured by antidepressants is expected to decrease with generics dominating the market during the forecast period
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the global market across major regions and segments.
- Competitive Landscape: Explore the market presence of key players worldwide.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the global market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segment and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listing for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 2 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. Anxiety Disorders and Depression Treatment Market Variables, Trends, & Scope
Chapter 4. Anxiety Disorders and Depression Treatment Market Variables : Drugs Estimates & Trend Analysis
Chapter 5. Anxiety Disorders and Depression Treatment Market : Indication Estimates & Trend Analysis
Chapter 6. Anxiety Disorders and Depression Treatment Market : Distribution Channel Estimates & Trend Analysis
Chapter 7. Anxiety Disorders and Depression Treatment Market : Regional Estimates & Trend Analysis
Chapter 8. Competitive Landscape
Companies Mentioned
- Pfizer Inc.
- H. Lundbeck A/S
- Glaxo SmithKline Pharmaceuticals Ltd.
- Merck & Co., Inc.
- Eli Lilly & Company
- AstraZeneca
- Bristol-Myers Squibb
- Johnson & Johnson
- AbbVie Inc.
- Sanofi
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 120 |
| Published | August 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 12.43 Billion |
| Forecasted Market Value ( USD | $ 15.88 Billion |
| Compound Annual Growth Rate | 3.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
